风湿消息
ACR 2025 “风”起东方 | 北京大学人民医院篇
点击蓝字，关注我们
在ACR 2025，中国学者持续展现出卓越的学术风采。据初步统计，2700多份摘要中共有130+份学术摘要被大会接收成功入选。在此，风湿免疫界对国内医院及研究所的成果进行了系统整理，以飨读者。
为助力国内同仁和广大读者及时追踪国际学术动态，「风湿免疫界」特别整理了国内医院/研究所的研究成果展示合集，本文梳理了来自北京大学人民医院(第一作者/通讯单位)的12篇摘要，一起先睹为快吧~
Poster
Low-dose Interleukin-2 Therapy in Systemic Lupus Erythematosus: a double-blind, randomised, placebo-controlled, phase IIb trial
摘要号:LB01
作者:
Xia Zhang, Ruiling Feng, Zhanguo Li and Jing He
报告专场：
(LB01–LB18) Late-Breaking Posters
报告时间：
Tuesday, October 28, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.28 23:30-01:30 UTC+8（北京时间）
Tofacitinib Plus Glucocorticoids Can Effectively Reduce Relapse Rate in IgG4-Related Disease: A Randomized,Open-label controlled Trial
摘要号:LB02
作者:
Xi Xu, Huaqun Zhu and Hua Ye
报告专场：
(LB01–LB18) Late-Breaking Posters
报告时间：
Tuesday, October 28, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.28 23:30-01:30 UTC+8（北京时间）
Circulating biomarkers for organ involvement in systemic lupus erythematosus: a series of systematic reviews and meta-analyses
摘要号:LB17
作者:
Sitian Zang, Ranran Yao , Yan Wang , Danxue Zhu, Jing He and Zhanguo Li
报告专场：
(LB01–LB18) Late-Breaking Posters
报告时间：
Tuesday, October 28, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.28 23:30-01:30 UTC+8（北京时间）
Cerebral small vessel disease in antiphospholipid syndrome: subtypes and total burden of cSVD on MRI
摘要号:0116
作者:
Chun Li, Jianping Guo, Yangyi Fan, Yu Kang and Xiaodan Hu
报告专场：
(0115–0144) Antiphospholipid Syndrome Poster
报告时间：
Sunday, October 26, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.26 23:30-01:30 UTC+8（北京时间）
Increased Expression of Gas6 and Its Tyrosine Kinase Receptor Tyro3 Are Associated with Antiphospholipid Syndrome
摘要号:0132
作者:
Fanshu Li, Ranran Yao, Fanlei Hu, Liling Xu and Chun Li
报告专场：
(0115–0144) Antiphospholipid Syndrome Poster
报告时间：
Sunday, October 26, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.26 23:30-01:30 UTC+8（北京时间）
Cytokine profiles in antiphospholipid syndrome
摘要号:0141
作者:
Xiangjun Liu , Yuzhou Gan , Chun Li , Jianping Guo , lei zhu and yuan jia
报告专场：
(0115–0144) Antiphospholipid Syndrome Poster
报告时间：
Sunday, October 26, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.26 23:30-01:30 UTC+8（北京时间）
High-dimensional Spectral Flow Cytometry Reveals a Unique Distribution of Circulating B Cells in Patients with Antiphospholipid Syndrome
摘要号:0147
作者:
Yuzhou Gan, Srilakshmi Yalavarthi, Xiangjun Liu, Yiran Shen, Cyrus Sarosh, Ajay Tambralli, Jacqueline A. Madison, Yu Zuo, and Jason S. Knight
报告专场：
(0115–0144) Antiphospholipid Syndrome Poster
报告时间：
Sunday, October 26, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.26 23:30-01:30 UTC+8（北京时间）
Biomarker landscape for neuropsychiatric involvement in patient with systemic lupus erythematosus
摘要号:1510
作者:
Sitian Zang, Ranran Yao and Zhanguo Li
报告专场：
(1467–1516) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster II
报告时间：
Monday, October 27, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.27 23:30-01:30 UTC+8（北京时间）
Serum Antigenome Profiling Reveals Diagnostic Models for Systemic Lupus Erythematosus
摘要号:1514
作者:
Yan Wang, Lulu Cao, Mengze Xu, Jian Lu, Jing He, Fanlei Hu and Zhanguo Li
报告专场：
(1467–1516) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster II
报告时间：
Monday, October 27, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.27 23:30-01:30 UTC+8 (北京时间）
Machine Learning–defined Subtypes of Systemic Lupus Erythematosus Identify Distinct Immunologic and Molecular Signatures
摘要号:1515
作者:
Yuke Hou, Bo Wei, Jingyuan Liang, Yujia Zhai, Yan Wang, Haihong Yao and Zhanguo Li
报告专场：
(1467–1516) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster II
报告时间：
Monday, October 27, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.27 23:30-01:30 UTC+8（北京时间）
Metabolic impact of low dose IL‐2 therapy for primary Sjögren’s Disease in a double‐blind, randomized clinical trial
摘要号:2303
作者:
Ruiling Feng, Bo Huang and Yuebo Jin
报告专场：
(2290–2304) Sjögren’s Disease – Basic & Clinical Science Poster III: Treatment and Trial Outcome Measures
报告时间：
Tuesday, October 28, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.28 23:30-01:30 UTC+8（北京时间）
IMC-002 (IMM0306), a First-in-Class Bi-specific Fusion Protein, Demonstrates Improvements in Systemic Lupus Erythematosus (SLE) Disease Activity Measures and Biomarkers in Patients with Moderate to Severe Active SLE in the Open-label Phase 1b/2 Study
摘要号:2464
作者:
Haihong Yao, Wenzhi Tian, Qian Zheng, Min Chen, Guoping Jiang, Zhichun Liu, Yingkun Nie, Rui Wu, Zhaohui Zheng and Zhanguo Li
报告专场：
(2437–2469) Systemic Lupus Erythematosus – Treatment Poster III
报告时间：
Tuesday, October 28, 2025
10:30AM-12:30PM UTC-5（芝加哥时间）
10.28 23:30-01:30 UTC+8 (北京时间）
风湿免疫界
将继续给您带来ACR 大会
独家报道和资料！
带您走进ACR！
持续更新，敬请期待......
审核：何菁、赵静
总编：龚丽
版权所有 © 北京大学人民医院风湿免疫研究所
技术支持：优河马